News & Media

Media

FEATURED

Learn more about our ACCUM technology

Making a Global Impact

News Releases

2026 Audited Financial Statement and MD&A

2026 Audited Financial Statement and MD&A

2026 Audited FS 2026 MD&AAbout Defence: Defence Therapeutics is a publicly traded biotechnology company committed to making cancer treatment more effective and safer. Using its Accum® precision drug delivery platform, Defence is working to enhance the potency of...

read more

Learn more about our biopharmacutical innovations for future generations.